Author Correction: Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation

Defang Li, Jin Liu, Baosheng Guo, Chao Liang, Lei Dang, Cheng Lü, Xiaojuan He, Hilda Yeuk-Siu Cheung, Liang Xu, Changwei Lu, Bing He, Biao Liu, Atik Badshah Shaikh, Fangfei Li, Luyao Wang, Zhijun Yang, Doris W.t. Au, Songlin Peng, Zongkang Zhang, Bao‐Ting Zhang, Xiaohua Pan, Airong Qian, Peng Shang, Lianbo Xiao, Baohong Jiang, Chris K.c. Wong, Jiake Xu, Zhaoxiang Bian, Zicai Liang, De‐an Guo, Hailong Zhu, Weihong Tan, Aiping Lü, Ge ZhangNature Communications 2025 · DOI · OpenAlex

Abstract

This article provides a formal correction to the 2016 study "Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation." The correction addresses inadvertent image duplications and misplacements in the original Figures 3 and 4, specifically involving microscopy and microCT data. Despite these administrative errors in image management, the authors confirm that the underlying raw data and statistical analyses remain sound. The study's core conclusion—that osteoclasts utilize exosomal miR-214-3p as a paracrine signal to inhibit osteoblast activity—is fully supported by the corrected evidence.

Introduction

The maintenance of skeletal integrity relies on the delicate balance between bone resorption by osteoclasts and bone formation by osteoblasts. Pathological bone loss, such as that seen in osteoporosis, often results from an imbalance where resorption exceeds formation. While it has long been known that these two cell types communicate, the specific signaling molecules involved in this "coupling" are a subject of intense research. This study identifies miR-214-3p, packaged within osteoclast-derived exosomes, as a potent inhibitor of osteoblastic bone formation.

Methods and Molecular Validation

The researchers utilized a conditional knock-in mouse model to overexpress miR-214-3p specifically in osteoclasts. This was achieved by crossing a Ctsk-Cre mouse line with a LoxP-flanked miR-214-3p line. To confirm the success of this genetic manipulation, the team isolated exosomes from both serum and bone marrow-derived osteoclasts using ultracentrifugation.

Molecular analysis via qPCR confirmed a significant increase in miR-214-3p levels within osteoclasts and their secreted exosomes. Furthermore, the expression of key osteoblastic markers—including alkaline phosphatase (ALP), osteopontin (OPN), bone sialoprotein (BSP), and osteocalcin (BGLAP)—was significantly downregulated in the bone specimens of these transgenic mice, indicating a suppression of bone-building activity at the genetic level.

Genetic strategy and molecular validation of miR-214-3p overexpression in osteoclasts and its impact on bone formation markers.

Key Results: Impact on Bone Structure

The physiological consequence of miR-214-3p overexpression was a marked reduction in bone mass. Micro-computed tomography (microCT) imaging of the femurs from OC-miR-214-3p mice showed a clear decrease in bone mineral density and a more porous trabecular structure compared to wild-type (WT) littermates.

MicroCT imaging of bone structure in WT versus OC-miR-214-3p mice, demonstrating reduced bone mass in the transgenic group.

Histomorphometric analysis further revealed a decrease in the Bone Formation Rate (BFR) and Mineral Apposition Rate (MAR), proving that the observed bone loss was driven by impaired osteoblast function. Crucially, the study also demonstrated that neutralizing miR-214-3p with specific antagomirs could rescue bone mass, suggesting that this pathway is a viable target for therapeutic intervention in bone-wasting diseases.

Conclusion

The corrections detailed in this document ensure the integrity of the visual evidence supporting the role of exosomal miR-214-3p in bone remodeling. By identifying this specific microRNA as a messenger of inhibition, the research opens new avenues for treating osteoporosis and other conditions characterized by excessive bone resorption and inadequate formation. The authors maintain that the errors in the original publication were administrative and do not affect the study's significant findings or biological conclusions.

Summary updated

Abstract

In the version of the article initially published, the microscopic image of 'WT' group in Fig. 3h was identical to the image of 'WT+Veh' group in Fig. 4d.The microCT image of 'OC214-3p+Veh' group in Fig. 4b was chosen from a wrong sample.We confirm that the inadvertent image duplication and misplacement occurred due to improper naming when exporting the original imaging data, which have now been replaced by the correct images in the corresponding figures (see Figs. 1 and 2 below).Raw data for both Figs. 3 and4 can be accessed at https://doi.org/10. 6084/m9.figshare.28915727.v1.The error and corrections do not alter the significance of findings or conclusions of this study.We apologize for any confusion these mistakes may have created.
BibTeX
@inproceedings{li2025author,
  author = {Defang Li and Jin Liu and Baosheng Guo and Chao Liang and Lei Dang and Cheng Lü and Xiaojuan He and Hilda Yeuk-Siu Cheung and Liang Xu and Changwei Lu and Bing He and Biao Liu and Atik Badshah Shaikh and Fangfei Li and Luyao Wang and Zhijun Yang and Doris W.T. Au and Songlin Peng and Zongkang Zhang and Bao‐Ting Zhang and Xiaohua Pan and Airong Qian and Peng Shang and Lianbo Xiao and Baohong Jiang and Chris K.C. Wong and Jiake Xu and Zhaoxiang Bian and Zicai Liang and De‐an Guo and Hailong Zhu and Weihong Tan and Aiping Lü and Ge Zhang},
  title = {{Author Correction: Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation}},
  booktitle = {Nature Communications},
  year = {2025},
  doi = {10.1038/s41467-025-61082-9},
}
Figure